William Geist Power - 03 Nov 2025 Form 4 Insider Report for BIO-TECHNE Corp (TECH)

Reporting relationship
PRESIDENT, PROTEIN SCIENCES
Issuer ticker
TECH
Reported as of
03 Nov 2025
Net transaction value
-$282,816
Source evidence Original filing metadata and source links for verification. 4 source fields
SEC form
4
Accepted by SEC
05 Nov 2025, 16:46:25 UTC
Prior SEC filing
19 Aug 2025
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Andrew Nick as Attorney-in-Fact for William Geist pursuant to Power of Attorney previously filed

Key filing fact

William Geist Power filed Form 4 for BIO-TECHNE Corp (TECH) on 05 Nov 2025.

Key facts

  • This page summarizes William Geist Power's Form 4 filing for BIO-TECHNE Corp (TECH).
  • 3 reported transactions and 12 derivative rows are listed below.
  • Accepted by SEC: 05 Nov 2025, 16:46.

Change

  • Previous filing in this sequence was filed on 19 Aug 2025.
  • Current net transaction value: -$282,816.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001832210 Primary reporting owner

Geist William

Relationship
PRESIDENT, PROTEIN SCIENCES
Address
614 MCKINLEY PLACE NE, MINNEAPOLIS
Signature
/s/ Andrew Nick as Attorney-in-Fact for William Geist pursuant to Power of Attorney previously filed
Signature date
05 Nov 2025

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

TECH transaction

Common Stock

Options Exercise

Transaction value
$0
Shares
+9,911
Change %
+66%
Price
$0.000000
Shares after
25,023
Date
03 Nov 2025
Ownership
Direct
TECH transaction

Common Stock

Tax liability

Transaction value
$282,816
Shares
-4,520
Change %
-18%
Price
$62.57
Shares after
20,503
Date
03 Nov 2025
Ownership
Direct

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

TECH transaction Derivative

Restricted Stock Units

Options Exercise

Transaction value
$0
Shares
-9,911
Change %
-100%
Price
$0.000000
Shares after
0
Date
03 Nov 2025
Ownership
Direct
Underlying class
Common Stock
Underlying amount
9,911
Exercise price
Footnotes
F1, F6
TECH holding Derivative

Stock Options (Right to Buy)

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
15,912
Date
03 Nov 2025
Ownership
Direct
Underlying class
Common Stock
Underlying amount
15,912
Exercise price
$100.39
Footnotes
F2
TECH holding Derivative

Stock Options (Right to Buy)

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
29,600
Date
03 Nov 2025
Ownership
Direct
Underlying class
Common Stock
Underlying amount
29,600
Exercise price
$94.52
Footnotes
F3
TECH holding Derivative

Performance Restricted Stock Units

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
9,074
Date
03 Nov 2025
Ownership
Direct
Underlying class
Common Stock
Underlying amount
9,074
Exercise price
Footnotes
F1, F4
TECH holding Derivative

Performance Stock Options (Right to Buy)

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
24,424
Date
03 Nov 2025
Ownership
Direct
Underlying class
Common Stock
Underlying amount
24,424
Exercise price
$84.61
Footnotes
F4
TECH holding Derivative

Stock Options (Right to Buy)

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
30,059
Date
03 Nov 2025
Ownership
Direct
Underlying class
Common Stock
Underlying amount
30,059
Exercise price
$84.61
Footnotes
F5
TECH holding Derivative

Performance Restricted Stock Units

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
15,738
Date
03 Nov 2025
Ownership
Direct
Underlying class
Common Stock
Underlying amount
15,738
Exercise price
Footnotes
F1, F7
TECH holding Derivative

Restricted Stock Units

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
5,246
Date
03 Nov 2025
Ownership
Direct
Underlying class
Common Stock
Underlying amount
5,246
Exercise price
Footnotes
F1, F8
TECH holding Derivative

Stock Options (Right to Buy)

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
21,204
Date
03 Nov 2025
Ownership
Direct
Underlying class
Common Stock
Underlying amount
21,204
Exercise price
$74.91
Footnotes
F9
TECH holding Derivative

Performance Restricted Stock Units

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
19,355
Date
03 Nov 2025
Ownership
Direct
Underlying class
Common Stock
Underlying amount
19,355
Exercise price
Footnotes
F1, F10
TECH holding Derivative

Restricted Stock Units

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
9,678
Date
03 Nov 2025
Ownership
Direct
Underlying class
Common Stock
Underlying amount
9,678
Exercise price
Footnotes
F1, F11
TECH holding Derivative

Stock Options (Right to Buy)

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
24,758
Date
03 Nov 2025
Ownership
Direct
Underlying class
Common Stock
Underlying amount
24,758
Exercise price
$53.60
Footnotes
F12
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 12 footnotes

Footnote F1

Each restricted stock unit represents a contingent right to receive one share of Bio-Techne common stock.

Footnote F2

Options to purchase 3,980 shares vest on each of 2/1/2023 and 2/1/2025, and options to purchase 3,976 shares vest on each of 2/1/2024 and 2/1/2026.

Footnote F3

Options to purchase 7,400 shares vest on each of 8/15/2023, 8/15/2024, 8/15/2025 and 8/15/2026.

Footnote F4

Vests in full or in part on 8/15/2026 if certain performance goals are achieved (or such later date as performance is certified by the Administrator).

Footnote F5

Options to purchase 7,515 shares vest on each of 8/15/2024, 8/15/2025, 8/15/2027, and 7,514 shares vest on 8/15/2026.

Footnote F6

9,911 restricted stock units vest on 11/1/2025.

Footnote F7

Vests in full or in part on 8/15/2027 if certain performance goals are achieved (or such later date as performance is certified by the Administrator).

Footnote F8

2,623 restricted stock units vest on each of 8/15/2026 and 8/15/2027.

Footnote F9

Options to purchase 5,301 shares vest on each of 8/15/2025, 8/15/2026, 8/15/2027 and 8/15/2028.

Footnote F10

Vests in full or in part on 8/15/2028 if certain performance goals are achieved (or such later date as performance is certified by the Administrator).

Footnote F11

3,226 restricted stock units vest on each of 8/15/2026, 8/15/2027 and 8/15/2028.

Footnote F12

Options to purchase 8,253 shares vest on each of 8/15/2026 and 8/15/2027, and options to purchase 8,252 shares vest on 8/15/2028.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .